Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Late diagnosis and poor nutrition in cystic fibrosis diagnosed before implementation of newborn screening.

Pedersen MG, Højte C, Olesen HV, Pressler T, Skov M.

Acta Paediatr. 2019 Jun 19. doi: 10.1111/apa.14908. [Epub ahead of print]

PMID:
31218749
2.

Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis.

Drevinek P, Pressler T, Cipolli M, De Boeck K, Schwarz C, Bouisset F, Boff M, Henig N, Paquette-Lamontagne N, Montgomery S, Perquin J, Tomkinson N, den Hollander W, Elborn JS.

J Cyst Fibros. 2019 Jun 7. pii: S1569-1993(19)30766-0. doi: 10.1016/j.jcf.2019.05.014. [Epub ahead of print]

3.

Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose.

Mathiesen IH, Hitz MF, Katzenstein TL, Oturai P, Skov M, Jørgensen NR, Jensen PO, Mikkelsen CR, Krogh-Madsen R, Pressler T, Faurholt-Jepsen D.

J Cyst Fibros. 2019 May;18(3):436-441. doi: 10.1016/j.jcf.2019.01.004. Epub 2019 Mar 28.

PMID:
30928333
4.

Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections.

Hengzhuang W, Green K, Pressler T, Skov M, Katzenstein TL, Wu X, Høiby N.

Pediatr Pulmonol. 2019 May;54(5):575-580. doi: 10.1002/ppul.24269. Epub 2019 Feb 25.

PMID:
30803159
5.

Cystic fibrosis - an example of personalized and precision medicine.

Skov M, Hansen CR, Pressler T.

APMIS. 2019 May;127(5):352-360. doi: 10.1111/apm.12915. Epub 2019 Feb 14. Review.

PMID:
30761610
6.

Can secretory immunoglobulin A in saliva predict a change in lung infection status in patients with cystic fibrosis? A prospective pilot study.

Alanin MC, Pressler T, Aanaes K, Ekstrøm CT, Skov M, Johansen HK, Nielsen KG, von Buchwald C, Høiby N.

Health Sci Rep. 2018 Jul 12;1(8):e52. doi: 10.1002/hsr2.52. eCollection 2018 Aug.

7.

Antibody response against Mycobacterium avium complex in cystic fibrosis patients measured by a novel IgG ELISA test.

Ravnholt C, Qvist T, Kolpen M, Pressler T, Skov M, Høiby N.

J Cyst Fibros. 2019 Jul;18(4):516-521. doi: 10.1016/j.jcf.2018.11.011. Epub 2018 Nov 29.

PMID:
30503330
8.

The importance of early diagnosis of Mycobacterium abscessus complex in patients with cystic fibrosis.

Ravnholt C, Kolpen M, Skov M, Moser C, Katzenstein TL, Pressler T, Høiby N, Qvist T.

APMIS. 2018 Dec;126(12):885-891. doi: 10.1111/apm.12903. Review.

PMID:
30456869
9.

Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations.

Qvist T, Schlüter DK, Rajabzadeh V, Diggle PJ, Pressler T, Carr SB, Taylor-Robinson D.

J Cyst Fibros. 2019 May;18(3):390-395. doi: 10.1016/j.jcf.2018.10.006. Epub 2018 Oct 19.

10.

Impact of cystic fibrosis on birthweight: a population based study of children in Denmark and Wales.

Schlüter DK, Griffiths R, Adam A, Akbari A, Heaven ML, Paranjothy S, Nybo Andersen AM, Carr SB, Pressler T, Diggle PJ, Taylor-Robinson D.

Thorax. 2019 May;74(5):447-454. doi: 10.1136/thoraxjnl-2018-211706. Epub 2018 Jul 19.

11.

The choice of lung function reference equation affects clinical trial eligibility: Results from a cystic fibrosis cohort.

Mathiesen IH, Ronit A, Pressler T.

J Cyst Fibros. 2018 Sep;17(5):e46-e47. doi: 10.1016/j.jcf.2018.05.017. Epub 2018 Jun 20. No abstract available.

PMID:
29934202
12.

Osteoporosis Is Associated with Deteriorating Clinical Status in Adults with Cystic Fibrosis.

Mathiesen IH, Pressler T, Oturai P, Katzenstein TL, Skov M, Frikke-Schmidt R, Hitz MF.

Int J Endocrinol. 2018 Mar 26;2018:4803974. doi: 10.1155/2018/4803974. eCollection 2018.

13.

Living with cystic fibrosis - a qualitative study of a life coaching intervention.

Knudsen KB, Boisen KA, Katzenstein TL, Mortensen LH, Pressler T, Skov M, Jarden M.

Patient Prefer Adherence. 2018 Apr 19;12:585-594. doi: 10.2147/PPA.S159306. eCollection 2018.

14.

Aquagenic wrinkling of the palms in patients with cystic fibrosis.

Kaiser H, Brustad N, Pressler T, Bygum A.

Br J Dermatol. 2018 Aug;179(2):494-495. doi: 10.1111/bjd.16448. Epub 2018 May 6. No abstract available.

PMID:
29451691
15.

The effect of time-of-day and chest physiotherapy on multiple breath washout measures in children with clinically stable cystic fibrosis.

Voldby C, Green K, Rosthøj S, Kongstad T, Philipsen L, Buchvald F, Skov M, Pressler T, Gustafsson P, Nielsen KG.

PLoS One. 2018 Jan 10;13(1):e0190894. doi: 10.1371/journal.pone.0190894. eCollection 2018.

16.

Variability of monthly nitrogen multiple-breath washout during one year in children with cystic fibrosis.

Green K, Kongstad T, Skov M, Buchvald F, Rosthøj S, Marott JL, Gustafsson P, Pressler T, Nielsen KG.

J Cyst Fibros. 2018 Mar;17(2):242-248. doi: 10.1016/j.jcf.2017.11.007. Epub 2017 Dec 19.

PMID:
29273421
17.

Prevalence and characteristics of chronic kidney disease among Danish adults with cystic fibrosis.

Berg KH, Ryom L, Faurholt-Jepsen D, Pressler T, Katzenstein TL.

J Cyst Fibros. 2018 Jul;17(4):478-483. doi: 10.1016/j.jcf.2017.11.001. Epub 2017 Dec 1.

PMID:
29187303
18.

Coach to cope: feasibility of a life coaching program for young adults with cystic fibrosis.

Knudsen KB, Pressler T, Mortensen LH, Jarden M, Boisen KA, Skov M, Quittner AL, Katzenstein TL.

Patient Prefer Adherence. 2017 Sep 21;11:1613-1623. doi: 10.2147/PPA.S141267. eCollection 2017.

19.

Erratum to: Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis.

Knudsen KB, Pressler T, Mortensen LH, Jarden M, Skov M, Quittner AL, Katzenstein T, Boisen KA.

Springerplus. 2017 May 31;5(1):2119. doi: 10.1186/s40064-017-3789-1. eCollection 2016.

20.

Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis.

Kongstad T, Green K, Buchvald F, Skov M, Pressler T, Nielsen KG.

Eur Clin Respir J. 2017 May 2;4(1):1318027. doi: 10.1080/20018525.2017.1318027. eCollection 2017.

21.

Electronic applications for the CFQ-R scoring.

Ronit A, Gelpi M, Argentiero J, Mathiesen I, Nielsen SD, Pressler T, Quittner AL.

Respir Res. 2017 May 30;18(1):108. doi: 10.1186/s12931-017-0592-z.

22.

Diagnosis of biofilm infections in cystic fibrosis patients.

Høiby N, Bjarnsholt T, Moser C, Jensen PØ, Kolpen M, Qvist T, Aanaes K, Pressler T, Skov M, Ciofu O.

APMIS. 2017 Apr;125(4):339-343. doi: 10.1111/apm.12689. Review.

PMID:
28407432
23.

Boosting joint models for longitudinal and time-to-event data.

Waldmann E, Taylor-Robinson D, Klein N, Kneib T, Pressler T, Schmid M, Mayr A.

Biom J. 2017 Nov;59(6):1104-1121. doi: 10.1002/bimj.201600158. Epub 2017 Mar 21.

PMID:
28321912
24.

Small airway dysfunction in well-treated never-smoking HIV-infected individuals.

Ronit A, Mathiesen IH, Gelpi M, Benfield T, Gerstoft J, Pressler T, Christiansen A, Lundgren J, Vestbo J, Dam Nielsen S.

Eur Respir J. 2017 Mar 2;49(3). pii: 1602186. doi: 10.1183/13993003.02186-2016. Print 2017 Mar. No abstract available.

25.

Flying the nest: a challenge for young adults with cystic fibrosis and their parents.

Bregnballe V, Boisen KA, Schiøtz PO, Pressler T, Lomborg K.

Patient Prefer Adherence. 2017 Feb 13;11:229-236. doi: 10.2147/PPA.S124814. eCollection 2017.

26.

Individual pharmacokinetic variation leads to underdosing of ciprofloxacin in some cystic fibrosis patients.

Schultz AN, Høiby N, Nielsen XC, Pressler T, Dalhoff K, Duno M, Buchard A, Johansen HK, Wang H, Dalbøge CS.

Pediatr Pulmonol. 2017 Mar;52(3):319-323. doi: 10.1002/ppul.23638. Epub 2016 Nov 4.

PMID:
28221736
27.

Sinus surgery can improve quality of life, lung infections, and lung function in patients with primary ciliary dyskinesia.

Alanin MC, Aanaes K, Høiby N, Pressler T, Skov M, Nielsen KG, Johansen HK, von Buchwald C.

Int Forum Allergy Rhinol. 2017 Mar;7(3):240-247. doi: 10.1002/alr.21873. Epub 2016 Nov 23.

PMID:
27879058
28.

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Bryant JM, Grogono DM, Rodriguez-Rincon D, Everall I, Brown KP, Moreno P, Verma D, Hill E, Drijkoningen J, Gilligan P, Esther CR, Noone PG, Giddings O, Bell SC, Thomson R, Wainwright CE, Coulter C, Pandey S, Wood ME, Stockwell RE, Ramsay KA, Sherrard LJ, Kidd TJ, Jabbour N, Johnson GR, Knibbs LD, Morawska L, Sly PD, Jones A, Bilton D, Laurenson I, Ruddy M, Bourke S, Bowler IC, Chapman SJ, Clayton A, Cullen M, Daniels T, Dempsey O, Denton M, Desai M, Drew RJ, Edenborough F, Evans J, Folb J, Humphrey H, Isalska B, Jensen-Fangel S, Jönsson B, Jones AM, Katzenstein TL, Lillebaek T, MacGregor G, Mayell S, Millar M, Modha D, Nash EF, O'Brien C, O'Brien D, Ohri C, Pao CS, Peckham D, Perrin F, Perry A, Pressler T, Prtak L, Qvist T, Robb A, Rodgers H, Schaffer K, Shafi N, van Ingen J, Walshaw M, Watson D, West N, Whitehouse J, Haworth CS, Harris SR, Ordway D, Parkhill J, Floto RA.

Science. 2016 Nov 11;354(6313):751-757. doi: 10.1126/science.aaf8156.

29.

Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.

Fernández-Barat L, Ciofu O, Kragh KN, Pressler T, Johansen U, Motos A, Torres A, Hoiby N.

J Cyst Fibros. 2017 Mar;16(2):222-229. doi: 10.1016/j.jcf.2016.08.005. Epub 2016 Sep 17.

30.

Evaluation of a bovine antibody test for diagnosing Mycobacterium avium complex in patients with cystic fibrosis.

Qvist T, Pressler T, Katzenstein TL, Høiby N, Collins MT.

Pediatr Pulmonol. 2017 Jan;52(1):34-40. doi: 10.1002/ppul.23608. Epub 2016 Sep 20.

PMID:
27648735
31.

Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis.

Knudsen KB, Pressler T, Mortensen LH, Jarden M, Skov M, Quittner AL, Katzenstein T, Boisen KA.

Springerplus. 2016 Jul 29;5(1):1216. doi: 10.1186/s40064-016-2862-5. eCollection 2016. Erratum in: Springerplus. 2017 May 31;5(1):2119.

32.

Is genotyping of single isolates sufficient for population structure analysis of Pseudomonas aeruginosa in cystic fibrosis airways?

Sommer LM, Marvig RL, Luján A, Koza A, Pressler T, Molin S, Johansen HK.

BMC Genomics. 2016 Aug 9;17:589. doi: 10.1186/s12864-016-2873-1.

33.

Sinus surgery postpones chronic Gram-negative lung infection: cohort study of 106 patients with cystic fibrosis.

Alanin MC, Aanaes K, Høiby N, Pressler T, Skov M, Nielsen KG, Taylor-Robinson D, Waldmann E, Krogh Johansen H, von Buchwald C.

Rhinology. 2016 Sep;54(3):206-13. doi: 10.4193/Rhin15.347.

PMID:
27116399
34.

Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis.

Qvist T, Taylor-Robinson D, Waldmann E, Olesen HV, Hansen CR, Mathiesen IH, Høiby N, Katzenstein TL, Smyth RL, Diggle PJ, Pressler T.

J Cyst Fibros. 2016 May;15(3):380-5. doi: 10.1016/j.jcf.2015.09.007. Epub 2015 Oct 9.

35.

Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis.

Qvist T, Pressler T, Taylor-Robinson D, Katzenstein TL, Høiby N.

Eur Respir J. 2015 Sep;46(3):707-16. doi: 10.1183/09031936.00011815. Epub 2015 Apr 30.

36.

Low socioeconomic status and lung function.

Taylor-Robinson DC, Thielen K, Pressler T, Olesen HV, Diggle PJ.

Eur Respir J. 2015 Mar;45(3):857-8. doi: 10.1183/09031936.00232014. No abstract available.

37.

Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria--experiences from the Danish Cystic Fibrosis cohort study.

Qvist T, Johansen IS, Pressler T, Høiby N, Andersen AB, Katzenstein TL, Bjerrum S.

BMC Infect Dis. 2014 Dec 4;14:655. doi: 10.1186/s12879-014-0655-4.

38.

The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection -- a pilot study.

Skov M, Pressler T, Lykkesfeldt J, Poulsen HE, Jensen PØ, Johansen HK, Qvist T, Kræmer D, Høiby N, Ciofu O.

J Cyst Fibros. 2015 Mar;14(2):211-8. doi: 10.1016/j.jcf.2014.09.015. Epub 2014 Oct 23.

39.

Simultaneous sinus and lung infections in patients with primary ciliary dyskinesia.

Alanin MC, Johansen HK, Aanaes K, Høiby N, Pressler T, Skov M, Nielsen KG, von Buchwald C.

Acta Otolaryngol. 2015 Jan;135(1):58-63. doi: 10.3109/00016489.2014.962185. Epub 2014 Nov 5.

PMID:
25370419
40.

Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population.

Taylor-Robinson DC, Thielen K, Pressler T, Olesen HV, Diderichsen F, Diggle PJ, Smyth R, Whitehead M.

Eur Respir J. 2014 Nov;44(5):1363-6. doi: 10.1183/09031936.00063714. Epub 2014 Sep 3. No abstract available.

41.

Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.

Qvist T, Gilljam M, Jönsson B, Taylor-Robinson D, Jensen-Fangel S, Wang M, Svahn A, Kötz K, Hansson L, Hollsing A, Hansen CR, Finstad PL, Pressler T, Høiby N, Katzenstein TL; Scandinavian Cystic Fibrosis Study Consortium (SCFSC).

J Cyst Fibros. 2015 Jan;14(1):46-52. doi: 10.1016/j.jcf.2014.08.002. Epub 2014 Aug 30.

42.

The development of diabetes among Danish cystic fibrosis patients over the last two decades.

Knudsen KB, Mathiesen ER, Eriksen V, Skov M, Nielsen KG, Johannesen J, Pressler T.

Pediatr Diabetes. 2015 May;16(3):219-26. doi: 10.1111/pedi.12143. Epub 2014 Jun 1.

PMID:
24891216
43.

European Cystic Fibrosis Society Standards of Care: Quality Management in cystic fibrosis.

Stern M, Bertrand DP, Bignamini E, Corey M, Dembski B, Goss CH, Pressler T, Rault G, Viviani L, Elborn JS, Castellani C.

J Cyst Fibros. 2014 May;13 Suppl 1:S43-59. doi: 10.1016/j.jcf.2014.03.011. Review.

44.

Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.

Qvist T, Pressler T, Høiby N, Katzenstein TL.

Respir Res. 2014 Apr 11;15:41. doi: 10.1186/1465-9921-15-41.

45.

Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.

Kolpen M, Bjarnsholt T, Moser C, Hansen CR, Rickelt LF, Kühl M, Hempel C, Pressler T, Høiby N, Jensen PØ.

Clin Exp Immunol. 2014 Jul;177(1):310-9. doi: 10.1111/cei.12318.

46.

Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.

Kolpen M, Kühl M, Bjarnsholt T, Moser C, Hansen CR, Liengaard L, Kharazmi A, Pressler T, Høiby N, Jensen PØ.

PLoS One. 2014 Jan 17;9(1):e84353. doi: 10.1371/journal.pone.0084353. eCollection 2014.

47.

Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis.

Dalbøge CS, Nielsen XC, Dalhoff K, Alffenaar JW, Duno M, Buchard A, Uges DR, Jensen AG, Jürgens G, Pressler T, Johansen HK, Høiby N.

J Cyst Fibros. 2014 Mar;13(2):179-85. doi: 10.1016/j.jcf.2013.08.008. Epub 2013 Sep 10.

48.

Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?

Aanaes K, Johansen HK, Skov M, Buchvald FF, Hjuler T, Pressler T, Hoiby N, Nielsen KG, von Buchwald C.

Rhinology. 2013 Sep;51(3):222-30. doi: 10.4193/Rhino12.207.

PMID:
23943728
49.

Commentary: opportunities for innovation and improvement in advance care planning using a tethered patient portal in the electronic health record.

Bose-Brill S, Pressler TR.

J Prim Care Community Health. 2012 Oct 1;3(4):285-8. doi: 10.1177/2150131911435525. Epub 2012 Feb 14.

PMID:
23804174
50.

Achromobacter species in cystic fibrosis: cross-infection caused by indirect patient-to-patient contact.

Hansen CR, Pressler T, Ridderberg W, Johansen HK, Skov M.

J Cyst Fibros. 2013 Dec;12(6):609-15. doi: 10.1016/j.jcf.2013.05.004. Epub 2013 Jun 12.

Supplemental Content

Loading ...
Support Center